CNS
CRO for Central Nervous System (CNS) Clinical Trials in the USA, Europe and Asia
GCT has been specializing in neurodegenerative diseases and supported CNS clinical research since 2001. Our core staff and top-management possess neuroscience knowledge and maintain strong relationships with Key Opinion Leaders (KOLs) and high-recruiting investigative clinical sites. This enables us confidently identify major ICH-GCP certified centers, select most renowned investigators and experienced site teams with background in similar studies. We provide accurate and reliable clinical study feasibility analysis, including discussions with local experts and KOLs.
Prospective subjects 60
Contract to FPI, days for regulatory approval
of global enrollment to clinical trials 2
country in EU by number of clinical trials
Meet our Experts
Eugene Selivra,
MD
MD
President
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Being the founding member of numerous professional associations and research institutions, he has the knowledge, authority and enthusiasm to navigate clinical research programs in various regions and therapeutic areas.
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
CNS in blog
